Jinn-Shiun Chen

Title: Innovations in Colorectal Cancer Detection by Jinn-Shiun Chen

Introduction

Jinn-Shiun Chen is a notable inventor based in Tao-Yuan, Taiwan. He has made significant contributions to the field of medical diagnostics, particularly in the detection of colorectal cancer. His innovative work has the potential to improve early diagnosis and treatment outcomes for patients.

Latest Patents

Jinn-Shiun Chen holds a patent titled "Serological markers for detecting colorectal cancer and their application for inhibiting colorectal cancer cells." This patent focuses on the use of specific serological markers, including phospholipid scramblase1 (PLSCR1), stomatin-like protein 2 (STOML2), and transport protein Sec61β (SEC61β). These markers increase in expression in the blood during the early stages of colorectal cancer. The detection of these proteins or their induced autoantibodies in blood samples can be utilized for diagnosing colorectal cancer. Furthermore, these serological markers enhance detection efficiency and sensitivity, aiding in prognosis prediction. They are also applicable in developing detection devices and inhibiting the growth of colorectal cancer cells.

Career Highlights

Jinn-Shiun Chen is affiliated with Chang Gung University, where he continues to advance research in cancer diagnostics. His work has garnered attention for its innovative approach to utilizing serological markers in clinical applications.

Collaborations

Some of his notable coworkers include Err-Cheng Chan and Kuei-Tien Chen, who have contributed to his research endeavors.

Conclusion

Jinn-Shiun Chen's contributions to the field of colorectal cancer detection exemplify the importance of innovation in medical diagnostics. His patented work not only enhances early detection but also holds promise for improving patient outcomes.